S&P 500   4,205.45
DOW   33,093.34
QQQ   348.40
MarketBeat Week in Review – 5/22 - 5/26
Introducing MarketBeat All Access (Ad)
As Elizabeth Holmes heads to prison for fraud, many puzzle over her motives
New bill to build Athletics stadium on Las Vegas Strip caps Nevada's cost at $380 million
Introducing MarketBeat All Access (Ad)
Mechanical sails? Batteries? Shippers forming 'green corridors' to fast-track cleaner technologies
Baby eels remain one of America's most valuable fish after strong year in Maine
Wall Street Legend Who Called AMZN Crash Issues New Sell Alert (Ad)
Teen workers are in high demand for summer and commanding better pay
Biden, GOP reach tentative deal to raise debt ceiling, avoid calamitous US default
S&P 500   4,205.45
DOW   33,093.34
QQQ   348.40
MarketBeat Week in Review – 5/22 - 5/26
Introducing MarketBeat All Access (Ad)
As Elizabeth Holmes heads to prison for fraud, many puzzle over her motives
New bill to build Athletics stadium on Las Vegas Strip caps Nevada's cost at $380 million
Introducing MarketBeat All Access (Ad)
Mechanical sails? Batteries? Shippers forming 'green corridors' to fast-track cleaner technologies
Baby eels remain one of America's most valuable fish after strong year in Maine
Wall Street Legend Who Called AMZN Crash Issues New Sell Alert (Ad)
Teen workers are in high demand for summer and commanding better pay
Biden, GOP reach tentative deal to raise debt ceiling, avoid calamitous US default
S&P 500   4,205.45
DOW   33,093.34
QQQ   348.40
MarketBeat Week in Review – 5/22 - 5/26
Introducing MarketBeat All Access (Ad)
As Elizabeth Holmes heads to prison for fraud, many puzzle over her motives
New bill to build Athletics stadium on Las Vegas Strip caps Nevada's cost at $380 million
Introducing MarketBeat All Access (Ad)
Mechanical sails? Batteries? Shippers forming 'green corridors' to fast-track cleaner technologies
Baby eels remain one of America's most valuable fish after strong year in Maine
Wall Street Legend Who Called AMZN Crash Issues New Sell Alert (Ad)
Teen workers are in high demand for summer and commanding better pay
Biden, GOP reach tentative deal to raise debt ceiling, avoid calamitous US default
S&P 500   4,205.45
DOW   33,093.34
QQQ   348.40
MarketBeat Week in Review – 5/22 - 5/26
Introducing MarketBeat All Access (Ad)
As Elizabeth Holmes heads to prison for fraud, many puzzle over her motives
New bill to build Athletics stadium on Las Vegas Strip caps Nevada's cost at $380 million
Introducing MarketBeat All Access (Ad)
Mechanical sails? Batteries? Shippers forming 'green corridors' to fast-track cleaner technologies
Baby eels remain one of America's most valuable fish after strong year in Maine
Wall Street Legend Who Called AMZN Crash Issues New Sell Alert (Ad)
Teen workers are in high demand for summer and commanding better pay
Biden, GOP reach tentative deal to raise debt ceiling, avoid calamitous US default
Positive News SentimentPositive News
NASDAQ:ABCM

Abcam (ABCM) Stock Forecast, Price & News

$16.36
+0.05 (+0.31%)
(As of 05/26/2023 ET)
Compare
Today's Range
$15.91
▼
$16.53
50-Day Range
$12.62
▼
$17.90
52-Week Range
$12.48
▼
$18.38
Volume
1.24 million shs
Average Volume
922,999 shs
Market Capitalization
$3.75 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$23.00
ProfileAnalyst RatingsChartCompetitorsFinancialsInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial Media

Abcam MarketRank™ Forecast

Analyst Rating
Moderate Buy
2.50 Rating Score
Upside/​Downside
40.6% Upside
$23.00 Price Target
Short Interest
Healthy
0.26% of Shares Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
1.60mentions of Abcam in the last 14 days
Based on 5 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
26.83%
From $0.41 to $0.52 Per Share

Overall MarketRank™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.52 out of 5 stars

Medical Sector

150th out of 1,018 stocks

Biological Products, Except Diagnostic Industry

21st out of 170 stocks

See Top Rated MarketRank™ Stocks Here

ABCM stock logo

About Abcam (NASDAQ:ABCM) Stock

Abcam plc, a life science company, focuses on identifying, developing, and distributing reagents and tools for scientific research, diagnostics, and drug discovery. Its principal products include primary and secondary antibodies; conjugated antibodies and conjugation kits; singleplex and multiplex immunoassays; proteins and peptides that include cytokines; edited cell lines and lysates; and various other products, including cellular activity kits, miRNA kits, biochemicals, and cell signaling pathway tools. The company serves scientists and researchers in academic institutions and research institutes, as well as in pharmaceutical, biotechnology, and diagnostics companies. It has operations in the Americas, Europe, the Middle East, Africa, China, Japan, and rest of the Asia Pacific. The company sells its products online. Abcam plc was incorporated in 1998 and is headquartered in Cambridge, the United Kingdom.

Receive ABCM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Abcam and its competitors with MarketBeat's FREE daily newsletter.

ABCM Stock News Headlines

May 13, 2023 | americanbankingnews.com
Abcam plc (NASDAQ:ABCM) Sees Large Increase in Short Interest
May 9, 2023 | markets.businessinsider.com
SVB Securities Keeps Their Buy Rating on Abcam (ABCM)
May 27, 2023 | Behind the Markets (Ad)
"How war impacts the stock market"
Russia's invasion of Ukraine has already sent the stock market down 10%. But that's just the opening act for the new Russia-China Alliance. There's a major event involving China that's heating up... and it could boil over as soon as April 16th, 2023. Click Here to Learn How to Protect Your Retirement
May 4, 2023 | msn.com
Abcam to streamline and consolidate operations in bid to cut costs
May 4, 2023 | finance.yahoo.com
Abcam, plc Business Update
May 4, 2023 | americanbankingnews.com
Abcam (NASDAQ:ABCM) Reaches New 12-Month High at $17.76
May 1, 2023 | americanbankingnews.com
Royal Bank of Canada Boosts Abcam (NASDAQ:ABCM) Price Target to $23.00
April 19, 2023 | americanbankingnews.com
Abcam (NASDAQ:ABCM) Sees Unusually-High Trading Volume
May 27, 2023 | Behind the Markets (Ad)
BREAKING: Tiny biotech successfully treats blindness
There's a tiny biotech in Cambridge that's using a breakthrough technology to treat blindness. This company has already shown success in human trials... And Our research shows that anyone who gets in today could see a 46,751% return.
April 18, 2023 | americanbankingnews.com
Short Interest in Abcam plc (NASDAQ:ABCM) Declines By 25.4%
April 14, 2023 | nasdaq.com
Abcam (ABCM) Shares Cross Above 200 DMA
March 29, 2023 | americanbankingnews.com
Abcam plc (NASDAQ:ABCM) Sees Significant Growth in Short Interest
March 28, 2023 | finance.yahoo.com
ABCAM PLC: Final results for the year ended 31 December 2022
March 25, 2023 | americanbankingnews.com
Abcam plc Forecasted to Earn FY2023 Earnings of $0.40 Per Share (NASDAQ:ABCM)
March 24, 2023 | americanbankingnews.com
Abcam plc (NASDAQ:ABCM) to Post FY2023 Earnings of $0.45 Per Share, SVB Leerink Forecasts
March 22, 2023 | americanbankingnews.com
Abcam plc (NASDAQ:ABCM) to Post FY2024 Earnings of $0.51 Per Share, William Blair Forecasts
March 22, 2023 | americanbankingnews.com
Abcam plc to Post FY2024 Earnings of $0.51 Per Share, William Blair Forecasts (NASDAQ:ABCM)
March 21, 2023 | americanbankingnews.com
Contrasting Brookline Capital Acquisition (NASDAQ:BCAC) & Abcam (NASDAQ:ABCM)
March 10, 2023 | finance.yahoo.com
Abcam to Report Full Year Results on Monday, March 20, 2023
February 24, 2023 | finance.yahoo.com
Abcam plc (ABCM) Stock Historical Prices & Data - Yahoo Finance
December 14, 2022 | 247wallst.com
First Look Analysts Research Calls for Wednesday, December 14
November 11, 2022 | finance.yahoo.com
ABCAM PLC: Result of General Meeting - Shareholders approve AIM Delisting
May 6, 2022 | nasdaq.com
Abcam - ADR (Sponsored) Shares Fall 0.6% Below Previous 52-Week Low - Market Mover
February 22, 2022 | nasdaq.com
Abcam Becomes Oversold (ABCM)
January 4, 2022 | finanznachrichten.de
Abcam; Alamar Biosciences: Alamar Biosciences partners with Abcam to drive understanding of the human proteome
November 4, 2021 | finanznachrichten.de
Abcam; Nautilus Biotechnology, Inc.: Nautilus and Abcam Announce Strategic Partnership to Accelerate Exploration of the Proteome
September 13, 2021 | finance.yahoo.com
29% Constant Currency Revenue Growth in H2 as Lab Activity Gradually Recovers and Demand for Abcam In-house Products Increases
See More Headlines
Receive ABCM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Abcam and its competitors with MarketBeat's FREE daily newsletter.

ABCM Company Calendar

Today
5/27/2023
Fiscal Year End
12/31/2023
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Biological products, except diagnostic
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:ABCM
CUSIP
N/A
CIK
1492074
Web
www.abcam.com
Phone
44-0-12-2369-6000
Fax
N/A
Employees
1,760
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$23.00
High Stock Price Forecast
$23.00
Low Stock Price Forecast
$23.00
Forecasted Upside/Downside
+40.6%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.50
Research Coverage
2 Analysts

Profitability

EPS (Most Recent Fiscal Year)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
39.90
P/E Growth
1.77
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
1.27
Quick Ratio
0.93

Sales & Book Value

Annual Sales
$447.49 million
Price / Sales
8.38
Cash Flow
$0.60 per share
Price / Cash Flow
27.34
Book Value
$3.92 per share
Price / Book
4.17

Miscellaneous

Outstanding Shares
229,270,000
Free Float
213,842,000
Market Cap
$3.75 billion
Optionable
Not Optionable
Beta
0.64

Key Executives

  • Mr. Alan Thomas Hirzel BS (Age 55)
    M.B.A., M.S., MBA, MS, CEO & Exec. Director
    Comp: $1.49M
  • Mr. Michael Shaun Baldock B.A. (Age 59)
    CFO & Director
    Comp: $1.06M
  • Mr. Mark Dermody
    Interim CIO
  • James Staveley
    VP of Investor Relations
  • Marc Perkins
    Gen. Counsel & Company Sec.
  • Emma Sceats
    Sr. VP of Sales, Service & Bus. Devel.
  • Mr. Nick Skinner
    Sr. VP of HR
  • Mr. Mark Bushfield
    Sr. VP of Research & Innovation
  • Ms. Kirstie Speck BBusSc
    Head of Consumer Insights
  • Ms. Yvonne Chien
    Sr. VP of Customer Experience

Key Competitors

View All Competitors

Institutional Ownership

View All Institutional Transactions













ABCM Stock - Frequently Asked Questions

Should I buy or sell Abcam stock right now?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Abcam in the last twelve months. There are currently 1 hold rating and 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" ABCM shares.
View ABCM analyst ratings or view top-rated stocks.

What is Abcam's stock price forecast for 2023?

2 brokerages have issued twelve-month price targets for Abcam's stock. Their ABCM share price forecasts range from $23.00 to $23.00. On average, they predict the company's share price to reach $23.00 in the next twelve months. This suggests a possible upside of 40.6% from the stock's current price.
View analysts price targets for ABCM or view top-rated stocks among Wall Street analysts.

How have ABCM shares performed in 2023?

Abcam's stock was trading at $15.56 on January 1st, 2023. Since then, ABCM shares have increased by 5.1% and is now trading at $16.36.
View the best growth stocks for 2023 here.

Are investors shorting Abcam?

Abcam saw a drop in short interest during the month of May. As of May 15th, there was short interest totaling 603,500 shares, a drop of 15.2% from the April 30th total of 711,400 shares. Based on an average trading volume of 731,700 shares, the days-to-cover ratio is currently 0.8 days.
View Abcam's Short Interest.

What ETFs hold Abcam's stock?

ETFs with the largest weight of Abcam (NASDAQ:ABCM) stock in their portfolio include BlackRock Future Health ETF (BMED), Invesco Nasdaq Biotechnology ETF (IBBQ), iShares Biotechnology ETF (IBB), ProShares Ultra Nasdaq Biotechnology (BIB),

What guidance has Abcam issued on next quarter's earnings?

Abcam issued an update on its first quarter 2023 earnings guidance on Monday, April, 17th. The company provided EPS guidance of for the period. The company issued revenue guidance of $121.46 million-$121.46 million.

When did Abcam IPO?

(ABCM) raised $149 million in an initial public offering (IPO) on Thursday, October 22nd 2020. The company issued 9,000,000 shares at $16.52 per share. Morgan Stanley, BofA Securities, SVB Leerink, Lazard and William Blair served as the underwriters for the IPO.

What is Abcam's stock symbol?

Abcam trades on the NASDAQ under the ticker symbol "ABCM."

Who are Abcam's major shareholders?

Abcam's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Price T Rowe Associates Inc. MD (6.76%), Wellington Management Group LLP (6.39%), Harding Loevner LP (5.99%), Baillie Gifford & Co. (5.20%), Brown Capital Management LLC (4.25%) and Wasatch Advisors LP (3.55%).

How do I buy shares of Abcam?

Shares of ABCM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Abcam's stock price today?

One share of ABCM stock can currently be purchased for approximately $16.36.

How much money does Abcam make?

Abcam (NASDAQ:ABCM) has a market capitalization of $3.75 billion and generates $447.49 million in revenue each year.

How many employees does Abcam have?

The company employs 1,760 workers across the globe.

How can I contact Abcam?

The official website for the company is www.abcam.com. The company can be reached via phone at 44-0-12-2369-6000 or via email at investor.relations@abcam.com.

This page (NASDAQ:ABCM) was last updated on 5/27/2023 by MarketBeat.com Staff

My Account -